Tempus Wealth Planning LLC Sells 1,725 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Tempus Wealth Planning LLC trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 37.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,927 shares of the exchange traded fund’s stock after selling 1,725 shares during the period. Tempus Wealth Planning LLC’s holdings in SPDR S&P Biotech ETF were worth $278,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Ndwm LLC bought a new position in SPDR S&P Biotech ETF in the 1st quarter worth about $603,000. Financial Sense Advisors Inc. bought a new position in SPDR S&P Biotech ETF in the 1st quarter worth about $6,134,000. Fluent Financial LLC bought a new position in SPDR S&P Biotech ETF in the 1st quarter worth about $518,000. Abundance Wealth Counselors grew its stake in SPDR S&P Biotech ETF by 1.2% in the 1st quarter. Abundance Wealth Counselors now owns 94,176 shares of the exchange traded fund’s stock worth $8,936,000 after acquiring an additional 1,161 shares in the last quarter. Finally, Bourgeon Capital Management LLC grew its stake in SPDR S&P Biotech ETF by 18.1% in the 1st quarter. Bourgeon Capital Management LLC now owns 2,292 shares of the exchange traded fund’s stock worth $217,000 after acquiring an additional 352 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $90.87 on Friday. The company has a market capitalization of $6.93 billion, a P/E ratio of 11.47 and a beta of 1.11. The company’s 50-day simple moving average is $90.58 and its two-hundred day simple moving average is $90.94. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.